| 000 | 01400 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511182615.0 | ||
| 264 | 0 | _c19921110 | |
| 008 | 199211s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMotzer, R J | |
| 245 | 0 | 0 |
_aPhase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression. _h[electronic resource] |
| 260 |
_bCancer research _cOct 1992 |
||
| 300 |
_a5775-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGrowth Substances _xisolation & purification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRNA, Neoplasm _xisolation & purification |
| 650 | 0 | 4 |
_aSuramin _xadverse effects |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 700 | 1 | _aNanus, D M | |
| 700 | 1 | _aO'Moore, P | |
| 700 | 1 | _aScher, H I | |
| 700 | 1 | _aBajorin, D F | |
| 700 | 1 | _aReuter, V | |
| 700 | 1 | _aTong, W P | |
| 700 | 1 | _aIversen, J | |
| 700 | 1 | _aLouison, C | |
| 700 | 1 | _aAlbino, A P | |
| 773 | 0 |
_tCancer research _gvol. 52 _gno. 20 _gp. 5775-9 |
|
| 999 |
_c1400699 _d1400699 |
||